Skip to main content Back to Top
Advertisement

Comprehensive Medication Management and the role of GTMRx Institute

Broadcast Date: August 27, 2021

 

Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

Get the Medications Right Institute (GTMRx) believes that through team based comprehensive medication management (CMM), we can save lives, save money, and restore health through personalized, patient-centered, coordinated approach to medication. ASHP works closely with GTMRX to develop best practices, payment models, and policy to support CMM and to impact patient care. Every good healthcare team needs a good pharmacist to guard against medication misuse and open the path to achieving positive health outcomes from the use of medications. This podcast will explore ASHP’s role in GTMRx which works to optimize medication outcomes for patients through CMM.

SPEAKERS

Bayli LarsonBayli Larson, Pharm.D., M.S., BCPS is Strategic Initiatives Associate at ASHP in Bethesda, MD. In her role she helps manage and lead a variety of collaborative cross-organizational strategic activities to help advance ASHP’s mission and vision. Bayli recently completed the ASHP Executive Fellowship in Association Leadership and Management at ASHP and prior to that completed an ASHP-accredited PGY1 residency at UCHealth Memorial Hospital in Colorado Springs, Colo., and earned her Pharm.D. from the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences in 2018. She previously obtained a bachelor’s degree in Microbiology and a master’s degree in Environmental Health: Toxicology from Colorado State University.

Mary Ann KliethermesMary Ann Kliethermes received a BS in pharmacy from the University of Michigan in 1977 her Doctor of Pharmacy from the Philadelphia College of Pharmacy and Science in 1981. Her career includes clinical practice and management in hospital, home infusion, ambulatory practice and academia.  Her current position is Director of Medication Safety and Quality at the American Society of Health-System Pharmacists. Her expertise is in pharmacist reimbursement, medication optimization, safety and quality attainment associated pharmacist services; particularly in new health care models and value-based payment systems.  

She has served as Chair of the Section of Ambulatory Care for ASHP , represented ASHP at the Joint Commission Ambulatory Professional and Technical Advisory Group, the Care Transitions Work Group of the PCPI and the Ambulatory Patient Safety Technical Advisory Panel for ASPE/HHS. She is a member of the ASHP SAG on Clinical Practice Advancement.  Mary Ann has contributed to the Pharmacy Quality Alliance (PQA) since its inception. She has served as Chair, Executive Committee and Board member of PQA. She is past chair for the APhA PCMH/ACO SIG. Mary Ann has been awarded Pharmacist of the Year, Shining Star Award and the Amy Lodolce Mentorship Award from ICHP, the Distinguished Service Award and Distinguished Leadership in Health-System Pharmacy Practice from ASHP, CCP Outstanding Faculty Award and the Daniel B. Smith Practice Excellence award from APhA.

Hannah PostHannah Post is a current Executive Fellow in Association Leadership and Management at ASHP. She formerly completed a PGY1 at Wesley Medical Center in Wichita, Kansas. She earned her Pharm.D. from the University of Missouri Kansas City School of Pharmacy in 2020. She has been engaged in efforts with a number of professional associations and national organizations, including ASHP, the Missouri Pharmacy Association, the Missouri Society of Health System Pharmacists, and the Kansas Council of Health-System Pharmacy.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.